Skip to main content
Log in

Effect of T0901317 on Hepatic Proinflammatory Gene Expression in ApoE−/− Mice Fed a High-fat/high-cholesterol Diet

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Objective

In present study, we employed cDNA-based microarray technique to investigate the effect of a synthetic LXR ligand T0901317 on hepatic gene expression of proinflammatory cytokines in apolipoprotein E knockout mice fed an atherogenic diet.

Methods and results

Male 8-week-old apoE−/− mice were randomly divided into four groups, baseline group, vehicle group, prevention group and treatment group. All of the mice were fed a high-fat/high-cholesterol diet with or without LXR agonist T0901317 for 8 or 14 weeks. Gene array analysis found 17 atherosclerosis-related genes with a 2- to 8-fold difference in expression level between vehicle-treated group and T0901317-treated group. It induced mRNA expression of proinflammatory cytokine tumor necrosis factor (TNF), but inhibited gene expression of several other proinflammatory cytokines including interleukin (IL)-1α, IL-6, and IL-7 in the liver. C-reactive protein, TNF, matrix metalloproteinase-9, IL-1α, IL-6, and IL-7 were verified by real-time quantitative PCR. Next, enzyme-linked immunosorbent assay analyses showed up-regulation of TNFα levels and down-regulation of IL-α, IL-6, IL-7 levels in plasma sample.

Conclusion

The synthetic LXR agonist T0901317 has paradoxical roles in hepatic gene expression of proinflammatory cytokines in apoE−/− mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

LXR:

liver X receptor

apoE−/−:

apolipoprotein E knockout

TNF:

tumor necrosis factor

IL:

interleukin

MMP:

matrix metalloproteinase

CRP:

C-reactive protein

ELISA:

enzyme-linked immunosorbent assay

TG:

triglyceride

TC:

total cholesterol

HDL-C:

high density lipoprotein cholesterol

Apo:

apolipoprotein

INOS:

inducible nitric oxide synthase

COX2:

cyclooxygenase 2

LPS:

lipopolysaccharide

GAPDH:

glyceraldehyde-3-phosphate dehydrogenase

ABC:

ATP-binding cassette transporter

ECM:

extracellular matrix

22(R)-HC:

22(R)-hydroxycholesterol

9cRA:

9-cis-retinoic acid

GR:

glucocorticoid receptor

References

  1. Libby, P. 2002. Inflammation in atherosclerosis. Nature 420:868–874.

    Article  PubMed  CAS  Google Scholar 

  2. Lusis, A. J. 2000. Atherosclerosis. Nature 407:233–241.

    Article  PubMed  CAS  Google Scholar 

  3. Glass, C. K., and J. L. Witztum. 2001. Atherosclerosis: the road ahead. Cell 104:503–516.

    Article  PubMed  CAS  Google Scholar 

  4. Zitzer, H., W. Wente, M. B. Brenner, S. Sewing, K. Buschard, J. Gromada, and A. M. Efanov. 2006. Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology 147:3898–3905.

    Article  PubMed  CAS  Google Scholar 

  5. Tang, C. K., G. H. Yi, J. H. Yang, L. S. Liu, Z. Wang, C. G. Ruan, and Y. Z. Yang. 2004. Oxidized LDL upregulated ATP binding cassette transporter A1 in THP-1 macrophages. Acta Pharmacol. Sin. 25(5):581–586.

    PubMed  CAS  Google Scholar 

  6. Joseph, S. B., A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9:213–219.

    Article  PubMed  CAS  Google Scholar 

  7. Castrillo, A., S. B. Joseph, C. Marathe, D. J. Mangelsdorf, P. Tontonoz. 2003. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278:10443–10449.

    Article  PubMed  CAS  Google Scholar 

  8. Blaschke, F., Y. Takata, E. Caglayan, A. Collins, P. Tontonoz, W. A. Hsueh, and R. K. Tangirala. 2006. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ. Res. 99:e88–e99.

    Article  PubMed  CAS  Google Scholar 

  9. Fowler, A. J., M. Y. Sheu, M. Schmuth, J. Kao, J. W. Fluhr, L. Rhein, J. L. Collins, T. M. Willson, D. J. Mangelsdorf, P. M. Elias, and K. R. Feingold. 2003. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J. Invest. Dermatol. 120:246–255.

    Article  PubMed  CAS  Google Scholar 

  10. Terasaka, N., A. Hiroshima, A. Ariga, S. Honzumi, T. Koieyama, T. Inaba, and T. Fujiwara. 2005. Liver X receptor agonists inhibit tissue factor expression in macrophages. Febs J. 272:1546–1556.

    Article  PubMed  CAS  Google Scholar 

  11. Peet, D. J., S. D. Turley, W. Ma, B. A. Janowski, J. M. Lobaccaro, R. E. Hammer, and D. J. Mangelsdorf. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693–704.

    Article  PubMed  CAS  Google Scholar 

  12. Ratliff, E. P., A. Gutierrez, R. A. Davis. 2006. Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia. J. Lipid. Res. 47:1513–1520.

    Article  PubMed  CAS  Google Scholar 

  13. Joseph, S. B., E. McKilligin, L. Pei, M. A. Watson, A. R. Collins, B. A. Laffitte, M. Chen, G. Noh, J. Goodman, G. N. Hagger, J. Tran, T. K. Tippin, X. Wang, A. J. Lusis, W. A. Hsueh, R. E. Law, J. L. Collins, T. M. Willson, and P. Tontonoz. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. U. S. A. 99:7604–7609.

    Article  PubMed  CAS  Google Scholar 

  14. Terasaka, N., A. Hiroshima, T. Koieyama, N. Ubukata, Y. Morikawa, D. Nakai, and T. Inaba. 2003. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett. 536:6–11.

    Article  PubMed  CAS  Google Scholar 

  15. Lee, C. K., R. Weindruch, and T. A. Prolla. 2000. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25:294–297.

    Article  PubMed  CAS  Google Scholar 

  16. Cao, S. X., J. M. Dhahbi, P. L. Mote, and S. R. Spindler. 2001. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc. Natl. Acad. Sci. U. S. A. 98:10630–10635.

    Article  PubMed  CAS  Google Scholar 

  17. Levin, N., E. D. Bischoff, C. L. Daige, D. Thomas, C. T. Vu, R. A. Heyman, R. K. Tangirala, and I. G. Schulman. 2005. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25:135–142.

    Article  PubMed  CAS  Google Scholar 

  18. Marleau, S., D. Harb, K. Bujold, R. Avallone, K. Iken, Y. Wang, A. Demers, M. G. Sirois, M. Febbraio, R. L. Silverstein, A. Tremblay, and H. Ong. 2005. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. Faseb J. 19:1869–1871.

    PubMed  CAS  Google Scholar 

  19. Hansson, G. K., P. Libby, U. Schonbeck, and Z. Q. Yan. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91:281–291.

    Article  PubMed  CAS  Google Scholar 

  20. Libby, P, and Z. S. Galis. 1995. Cytokines regulate genes involved in atherogenesis. Ann. N. Y. Acad. Sci. 748:158–168; discussion 168–170.

    Article  PubMed  CAS  Google Scholar 

  21. Libby, P, P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105:1135–1143.

    Article  PubMed  CAS  Google Scholar 

  22. Recinos, A. 3rd, B. K. Carr, D. B. Bartos, I. Boldogh, J. R. Carmical, L. M. Belalcazar, and A. R. Brasier. 2004. Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. Physiol. Genomics 19:131–142.

    Article  PubMed  CAS  Google Scholar 

  23. Martinet, W, D. M. Schrijvers, G. R. De Meyer, J. Thielemans, M. W. Knaapen, A. G. Herman, and M. M. Kockx. 2002. Gene expression profiling of apoptosis-related genes in human atherosclerosis: upregulation of death-associated protein kinase. Arterioscler. Thromb. Vasc. Biol. 22:2023–2029.

    Article  PubMed  CAS  Google Scholar 

  24. Tracey, K. J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491–503.

    Article  PubMed  CAS  Google Scholar 

  25. Piecyk, M., S. Wax, A. R. Beck, N. Kedersha, M. Gupta, B. Maritim, S. Chen, C. Gueydan, V. Kruys, M. Streuli, and P. Anderson. 2000. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. Embo J. 19:4154–4163.

    Article  PubMed  CAS  Google Scholar 

  26. Dean, J. L., R. Wait, K. R. Mahtani, G. Sully, A. R. Clark, and J. Saklatvala. 2001. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol. 21:721–730.

    Article  PubMed  CAS  Google Scholar 

  27. Shurety, W., A. Merino-Trigo, D. Brown, D. A. Hume, and J. L. Stow. 2000. Localization and post-Golgi trafficking of tumor necrosis factor-alpha in macrophages. J. Interferon Cytokine Res. 20:427–438.

    Article  PubMed  CAS  Google Scholar 

  28. Landis, M. S., H. V. Patel, and J. P. Capone. 2002. Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-alpha from human monocytes. J. Biol. Chem. 277:4713–4721.

    Article  PubMed  CAS  Google Scholar 

  29. Galis, Z. S., C. Johnson, D. Godin, R. Magid, J. M. Shipley, R. M. Senior, and E. Ivan. 2002. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ. Res. 91:852–859.

    Article  PubMed  CAS  Google Scholar 

  30. Galis, Z. S., G. K. Sukhova, R. Kranzhofer, S. Clark, and P. Libby. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. U. S. A. 92:402–406.

    Article  PubMed  CAS  Google Scholar 

  31. Pasterkamp, G., A. H. Schoneveld, D. J. Hijnen, D. P. de Kleijn, H. Teepen, A. C. van der Wal, and C. Borst. 2000. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150:245–253.

    Article  PubMed  CAS  Google Scholar 

  32. Kirii, H., T. Niwa, Y. Yamada, H. Wada, K. Saito, Y. Iwakura, M. Asano, H. Moriwaki, and M. Seishima. 2003. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23:656–660.

    Article  PubMed  CAS  Google Scholar 

  33. Isoda, K., S. Sawada, N. Ishigami, T. Matsuki, K. Miyazaki, M. Kusuhara, Y. Iwakura, and F. Ohsuzu. 2004. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 24:1068–1073.

    Article  PubMed  CAS  Google Scholar 

  34. Blake, G. J., and P. M. Ridker. 2003. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J. Am. Coll. Cardiol. 41:37S–42S.

    Article  PubMed  CAS  Google Scholar 

  35. Aggarwal, S., and A. L. Gurney. 2002. IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71:1–8.

    PubMed  CAS  Google Scholar 

  36. Lee, J., W. H. Ho, M. Maruoka, R. T. Corpuz, D. T. Baldwin, J. S. Foster, A. D. Goddard, D. G. Yansura, R. L. Vandlen, W. I. Wood, and A. L. Gurney. 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276:1660–1664.

    Article  PubMed  CAS  Google Scholar 

  37. Heinrich, P. C., J. V. Castell, and T. Andus. 1990. Interleukin-6 and the acute phase response. Biochem. J. 265:621–636.

    PubMed  CAS  Google Scholar 

  38. Moshage, H. 1997. Cytokines and the hepatic acute phase response. J. Pathol. 181:257–266.

    Article  PubMed  CAS  Google Scholar 

  39. Karin, M., and L. Chang. 2001. AP-1-glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol. 169:447–451.

    Article  PubMed  CAS  Google Scholar 

  40. Herrlich, P. 2001. Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20:2465–2475.

    Article  PubMed  CAS  Google Scholar 

  41. Nissen, R. M., and K. R. Yamamoto. 2000. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14:2314–2329.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (30470720), Post-doctor Sciences Foundation of China (2005037157), and Hunan Provincial Natural Sciences Foundation of China (06jj5058).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chaoke Tang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dai, X., Ou, X., Hao, X. et al. Effect of T0901317 on Hepatic Proinflammatory Gene Expression in ApoE−/− Mice Fed a High-fat/high-cholesterol Diet. Inflammation 30, 105–117 (2007). https://doi.org/10.1007/s10753-007-9026-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-007-9026-2

Key words

Navigation